BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27091409)

  • 1. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.
    Zhang Y; Koneva LA; Virani S; Arthur AE; Virani A; Hall PB; Warden CD; Carey TE; Chepeha DB; Prince ME; McHugh JB; Wolf GT; Rozek LS; Sartor MA
    Clin Cancer Res; 2016 Sep; 22(18):4735-45. PubMed ID: 27091409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.
    Lu X; Jiang L; Zhang L; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Gao J; Su X; Yan F
    Neoplasia; 2019 Jun; 21(6):591-601. PubMed ID: 31055200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Host Cell Alterations in HPV Carcinogenesis.
    Litwin TR; Clarke MA; Dean M; Wentzensen N
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28771191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
    Seiwert TY; Zuo Z; Keck MK; Khattri A; Pedamallu CS; Stricker T; Brown C; Pugh TJ; Stojanov P; Cho J; Lawrence MS; Getz G; Brägelmann J; DeBoer R; Weichselbaum RR; Langerman A; Portugal L; Blair E; Stenson K; Lingen MW; Cohen EE; Vokes EE; White KP; Hammerman PS
    Clin Cancer Res; 2015 Feb; 21(3):632-41. PubMed ID: 25056374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
    Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
    Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtyping of Human Papillomavirus-Positive Cervical Cancers Based on the Expression Profiles of 50 Genes.
    Zhu X; Li S; Luo J; Ying X; Li Z; Wang Y; Zhang M; Zhang T; Jiang P; Wang X
    Front Immunol; 2022; 13():801639. PubMed ID: 35126391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.
    Liu S; de Medeiros MC; Fernandez EM; Zarins KR; Cavalcante RG; Qin T; Wolf GT; Figueroa ME; D'Silva NJ; Rozek LS; Sartor MA
    Clin Epigenetics; 2020 Nov; 12(1):175. PubMed ID: 33203436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative molecular profiling of HPV-induced squamous cell carcinomas.
    Koncar RF; Feldman R; Bahassi EM; Hashemi Sadraei N
    Cancer Med; 2017 Jul; 6(7):1673-1685. PubMed ID: 28556593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
    Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
    PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mutational landscape of recurrent versus nonrecurrent human papillomavirus-related oropharyngeal cancer.
    Harbison RA; Kubik M; Konnick EQ; Zhang Q; Lee SG; Park H; Zhang J; Carlson CS; Chen C; Schwartz SM; Rodriguez CP; Duvvuri U; Méndez E
    JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes.
    Qin T; Li S; Henry LE; Chou E; Cavalcante RG; Garb BF; D'Silva NJ; Rozek LS; Sartor MA
    Cancer Res Commun; 2023 Aug; 3(8):1701-1715. PubMed ID: 37654626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic Significance.
    Nooij LS; Ter Haar NT; Ruano D; Rakislova N; van Wezel T; Smit VTHBM; Trimbos BJBMZ; Ordi J; van Poelgeest MIE; Bosse T
    Clin Cancer Res; 2017 Nov; 23(22):6781-6789. PubMed ID: 28899974
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
    Keck MK; Zuo Z; Khattri A; Stricker TP; Brown CD; Imanguli M; Rieke D; Endhardt K; Fang P; Brägelmann J; DeBoer R; El-Dinali M; Aktolga S; Lei Z; Tan P; Rozen SG; Salgia R; Weichselbaum RR; Lingen MW; Story MD; Ang KK; Cohen EE; White KP; Vokes EE; Seiwert TY
    Clin Cancer Res; 2015 Feb; 21(4):870-81. PubMed ID: 25492084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
    Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
    Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
    Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
    Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
    Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
    J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
    Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
    Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus seropositivity and risks of head and neck cancer.
    Smith EM; Ritchie JM; Pawlita M; Rubenstein LM; Haugen TH; Turek LP; Hamsikova E
    Int J Cancer; 2007 Feb; 120(4):825-32. PubMed ID: 17131312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences.
    de Villiers EM; Gunst K; Stein H; Scherübl H
    Int J Cancer; 2004 Mar; 109(2):253-8. PubMed ID: 14750177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.